Original Research
Published on 16 May 2022
DIRAS2 Is a Prognostic Biomarker and Linked With Immune Infiltrates in Melanoma
in Skin Cancer
Frontiers in Oncology
doi 10.3389/fonc.2022.799185
- 3,105 views
- 8 citations
- Frontiers in Oncology
- Skin Cancer
- Articles
Type at least 3 characters
414 articles
Review
Published on 10 May 2022
The Dark Side of Melanin Secretion in Cutaneous Melanoma Aggressiveness
in Skin Cancer
Frontiers in Oncology
doi 10.3389/fonc.2022.887366
- 8,677 views
- 35 citations
Review
Published on 29 Apr 2022
Hypochlorous Acid: From Innate Immune Factor and Environmental Toxicant to Chemopreventive Agent Targeting Solar UV-Induced Skin Cancer
in Skin Cancer
Frontiers in Oncology
doi 10.3389/fonc.2022.887220
- 13,842 views
- 22 citations
Original Research
Published on 29 Apr 2022
Assessment of the Novel, Practical, and Prognosis-Relevant TNM Staging System for Stage I-III Cutaneous Melanoma
in Skin Cancer
Frontiers in Oncology
doi 10.3389/fonc.2022.738298
- 3,246 views
- 3 citations
Original Research
Published on 28 Apr 2022
Outcomes From Cytotoxic Chemotherapy Following Progression on Immunotherapy in Metastatic Melanoma: An Institutional Case-Series
in Skin Cancer
Frontiers in Oncology
doi 10.3389/fonc.2022.855782
- 2,819 views
- 7 citations
Review
Published on 27 Apr 2022
Loss of ‘Epidermal Melanin Unit’ Integrity in Human Skin During Melanoma-Genesis
in Skin Cancer
Frontiers in Oncology
doi 10.3389/fonc.2022.878336
- 7,724 views
- 21 citations
Original Research
Published on 21 Apr 2022
Exploring Tumor Immune Microenvironment and Its Associations With Molecular Characteristics in Melanoma
in Skin Cancer
Frontiers in Oncology
doi 10.3389/fonc.2022.821578
- 5,549 views
- 12 citations
Systematic Review
Published on 21 Apr 2022
Acceptability of Drugs in the Treatment of Unresectable/Metastatic BRAF V600-Mutant Melanoma: A Systematic Review and Network Meta-Analysis
in Skin Cancer
Frontiers in Oncology
doi 10.3389/fonc.2022.865656
- 3,849 views
- 1 citation
Review
Published on 19 Apr 2022
Mechanisms of Immunotherapy Resistance in Cutaneous Melanoma: Recognizing a Shapeshifter
in Skin Cancer
Frontiers in Oncology
doi 10.3389/fonc.2022.880876
- 7,208 views
- 34 citations
Original Research
Published on 14 Apr 2022
Hemato-Oncological Diseases as Risk Factor for Recurrence or Metastasis of Pleomorphic Dermal Sarcoma
in Skin Cancer
Frontiers in Oncology
doi 10.3389/fonc.2022.873771
- 1,788 views
- 6 citations
Original Research
Published on 14 Apr 2022
Improved Survival Prediction by Combining Radiological Imaging and S-100B Levels Into a Multivariate Model in Metastatic Melanoma Patients Treated With Immune Checkpoint Inhibition
in Skin Cancer
Frontiers in Oncology
doi 10.3389/fonc.2022.830627
- 2,185 views
- 5 citations
Original Research
Published on 11 Apr 2022
Cancer Progression Gene Expression Profiling Identifies the Urokinase Plasminogen Activator Receptor as a Biomarker of Metastasis in Cutaneous Squamous Cell Carcinoma
in Skin Cancer
Frontiers in Oncology
doi 10.3389/fonc.2022.835929
- 6,213 views
- 14 citations
Original Research
Published on 07 Apr 2022
Macrophage and T-Cell Infiltration and Topographic Immune Cell Distribution in Non-Melanoma Skin Cancer of the Head and Neck
in Skin Cancer
Frontiers in Oncology
doi 10.3389/fonc.2022.809687
- 2,843 views
- 4 citations
Original Research
Published on 04 Apr 2022
BRAF Inhibitor Resistance Confers Increased Sensitivity to Mitotic Inhibitors
in Skin Cancer
Frontiers in Oncology
doi 10.3389/fonc.2022.766794
- 3,152 views
- 5 citations
Case Report
Published on 31 Mar 2022
Case Report: Delayed Onset Multi-Organ Toxicities in a Melanoma Patient Achieving Complete Response to BRAF/MEK Inhibition
in Skin Cancer
Frontiers in Oncology
doi 10.3389/fonc.2022.836845
- 4,712 views
- 4 citations
Brief Research Report
Published on 28 Mar 2022
The Inflammatory Status of Soluble Microenvironment Influences the Capacity of Melanoma Cells to Control T-Cell Responses
in Skin Cancer
Frontiers in Oncology
doi 10.3389/fonc.2022.858425
- 2,910 views
- 3 citations